These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Morbidity and non-relapse mortality after allogeneic bone marrow transplantation in adult leukemia patients conditioned with busulfan plus cyclophosphamide: a retrospective comparison of oral versus intravenous busulfan. Kim SE; Lee JH; Choi SJ; Lee JH; Ryu SG; Lee KH Haematologica; 2005 Feb; 90(2):285-6. PubMed ID: 15710597 [TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplants. Managing BMT patients in alternate site health care settings with infusion therapy. Buchsel PC Contin Care; 1992; 11(1):27-9; 36. PubMed ID: 10150100 [No Abstract] [Full Text] [Related]
27. Care after bone marrow transplantation. Jackson T; McKeag N; Stuart J Nurs Times; 1997 Mar 12-18; 93(11):48-9. PubMed ID: 9121908 [TBL] [Abstract][Full Text] [Related]
28. [Transmitting competences developed during the care of children]. Warnet S Rev Infirm; 2006 Oct; (124):36-8. PubMed ID: 17396614 [No Abstract] [Full Text] [Related]
30. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Daga A; Muraglia A; Quarto R; Cancedda R; Corte G Gene Ther; 2002 Jul; 9(14):915-21. PubMed ID: 12085239 [TBL] [Abstract][Full Text] [Related]
31. A sieving device for preparing bone-marrow for intravenous infusion. PEGG DE Lancet; 1960 Mar; 1(7126):682-3. PubMed ID: 14431386 [No Abstract] [Full Text] [Related]
32. Adverse events after infusions of cryopreserved hematopoietic stem cells depend on non-mononuclear cells in the infused suspension and patient age. Milone G; Mercurio S; Strano A; Leotta S; Pinto V; Battiato K; Coppoletta S; Murgano P; Farsaci B; Privitera A; Giustolisi R Cytotherapy; 2007; 9(4):348-55. PubMed ID: 17573610 [TBL] [Abstract][Full Text] [Related]
33. Hematopoiesis capacity, immunomodulatory effect and ex vivo expansion potential of mesenchymal stem cells are not impaired by cryopreservation. Zhao ZG; Li WM; Chen ZC; You Y; Zou P Cancer Invest; 2008 May; 26(4):391-400. PubMed ID: 18443960 [TBL] [Abstract][Full Text] [Related]
34. [Towards the use of intravenous apoptotic leukocyte infusion as a cell-based therapy approach?]. Saas P; Bonnefoy F; Kleinclauss F; Sun Y; Tiberghien P; Gaugler B; Perruche S Transfus Clin Biol; 2008 Jun; 15(3):98-108. PubMed ID: 18524660 [TBL] [Abstract][Full Text] [Related]
35. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course. Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406 [TBL] [Abstract][Full Text] [Related]
36. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells. van Besien K; Margolin K; Champlin R; Forman S Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395 [TBL] [Abstract][Full Text] [Related]
37. A model for comprehensive care in bone marrow transplantation. Thompson J Oncol Nurs Forum; 1999 Jul; 26(6):976. PubMed ID: 10420413 [No Abstract] [Full Text] [Related]
38. [Bone marrow transplantation. Time of reflection on intensive care and ethics]. Ferreira B; David C; Moreno T Servir; 1994; 42(5):262-5. PubMed ID: 7732388 [No Abstract] [Full Text] [Related]
39. Bone marrow aspiration: technique, grafts, and reports. Smiler D; Soltan M Implant Dent; 2006 Sep; 15(3):229-35. PubMed ID: 16966895 [TBL] [Abstract][Full Text] [Related]
40. Types of bone-marrow and stem-cell transplant. Campbell K Nurs Times; 1997 Feb 12-18; 93(7):44-6. PubMed ID: 9095950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]